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This paper deals with the area of environmental epidemiology involving measurement of exposure and dose, health outcomes, and important con-
founding and modifying variables (including genotype and psychosocial factors). Using examples, we illustrate strategies for increasing the accuracy
of exposure and dose measurement that include dosimetry algorithms, pharmacokinetic models, biologic markers, and use of multiple measures.
Some limitations of these methods are described and suggestions are made about where formal evaluation might be helpful. We go on to discuss
methods for assessing the inaccuracies in exposure or dose measurements, including sensitivity analysis and validation studies. In relation to mea-
surement of health outcomes, we discuss some definitional issues and cover, among other topics, biologic effect markers and other early indicators
of disease. Because measurement error in covariates is also important, we consider the problems in measurement of common confounders and
effect modifiers. Finally, we cite some general methodologic research needs. - Environ Health Perspect 101(Suppl 4):49-57 (1993).
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Measuring Environmental
Exposure and Dose
Concepts
Environmental exposures can occur as a
result of contact with a variety ofelements
(air, water, soil) that, in turn, influence the
pathways for exposure (inhalation, inges-
tion, dermal). Individuals' interactions
with these elements are complex, and
therefore it is not surprising that exposure
assessment and dose estimation are formi-
dable challenges to those investigating the
health effects ofenvironmental agents.
The concepts of exposure and dose have
been elaborated in a series of recent publica-
tions issued by the Board on Environmental
Studies and Toxicology of the National
Academy ofSciences (1,2). The term expo-
sure refers to the concentration of an agent at
the boundary between an individual and the
environment aswell as the duration ofcontact
between the two, but dose refers to the
amount actually deposited or absorbed in the
body over a given time period. Although
internal dose is the ideal measure from the sci-
entific standpoint, regulation can deal only
with external exposures, and therefore one
may want to measure both exposureanddose.
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Individuals' exposures may be modified
by factors such as activity patterns, which
determine encounters with various sources
of exposure; bioavailability of the agent in
time and place; and the rate at which expo-
sure occurs (e.g., a relatively constant rate
versus a variable rate). From a given expo-
sure, a person's resultant dose will depend
on host characteristics, such as age, sex, and
metabolism. It also will reflect the suscep-
tibility oftarget tissue at the time ofexpo-
sure; any shielding provided by the body
(e.g., the placenta, the blood-brain barrier)
or modulation by buildings that attenuate
exposure to electric fields and gamma radi-
ation but can be a source of exposure to
radon; and the effect of concurrent expo-
sures, such as cigarette smoking or medica-
tions. Inaddition,onlypartcularcomponents
ofthe dose may be relevant to healtheffects.
For calculating dose-response relationships,
this biologically effective dose is what
ought to be quantified. But in many
instances it may be difficult to define what
the biologically effective dose is, much less
measure it. In any event, the definition is
time-dependent and subject to change along
with the state ofscientific knowledge, just as
measurement capabilities change with new
technology. Epidemiologists undoubtedly
need to prepare for a new generation of
studies in which measurement ofvariables
will involve data at the level ofthe gene. A
commitment ofresources, such as talent and
funding, could improve the state ofthe art in
exposure and dose assessment and potentially
yield better estimation ofexposure-response
relationships and more effective measures
ofenvironmental protection.
In the past, the methods used to assign
exposures in environmental health studies
were quite crude, and to some extent they
still are (e.g, pesticide usage patterns, resi-
dence near a point source of pollution).
Even in studies where disease has been
ascertained at the individual level, exposure
measures may be ecologic in nature and
based on average levels for a group. When
the group is defined in geographic terms,
exposure levels might be estimated from
values recorded by environmental sampling
in a subject's general vicinity. However,
recent research has shown that correlations
sometimes are weak between readings from
area monitors and subjects' exposures mea-
sured using personal monitors (3), which
are presumed to relate more closely to the
true dose. Discrepancies between readings
from personal and areawide samples can
result from heterogeneity of exposures,
from poor placement of samplers (e.g., air
monitors at elevations well above the
breathing zone), or from failure to take
account of human activity patterns and
other sources ofexposure.
Exposure monitoring systems can be and
are being improved, however. Newer
approaches include sampling the microenvi-
ronments where exposure principally occurs,
including indoor environments (e.g., bed-
rooms and living rooms in studies ofradon
and electric and magnetic fields), as well as
total exposure monitoring in which all
potentially relevant microenvironments are
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sampled (4,5). The latter approach is par-
ticularly important for ubiquitous com-
pounds like the polycyclic aromatic
hydrocarbons. To some extent, personal
exposure monitoring is also beginning to be
incorporated into environmental health
studies. In addition to these attempts to
improve externally derived measures of
exposure, efforts are being made to estimate
internal dose using strategies like empirical
dosimetric modeling, pharmacokinetic
modeling, and biologic markers.
Such efforts are important. The failure to
assign individual exposure and dose accu-
ratelyleads to measurement errors with con-
sequent effects on measures of association
(and, ultimately, risk assessments) that will
differdepending onwhether the error is ran-
dom or systematic and whether the unit of
analysis is the individual or the group.
Systematic error in exposure measurement
can introduce bias either toward or away
from the null. Random error tends to bias
results toward the null, although exceptions
to the rule can be found in unusual circum-
stances (6). For ecologic studies in which
exposure is a binary variable derived from
combinations ofindividual observations, the
rule stating random error generally biases
results toward the null maynothold (7).
Given the consequences oferror in esti-
mating exposure, it is important to try to
increase accuracy of measurement at the
design stage of a study. How, then, does
an investigator decide when the use of a
surrogate exposure measure (i.e., an error-
prone measure) is acceptable, and when it
is not? Rosner et al. have shown (8) that
for correlations between surrogate and true
measures of exposure less than 0.8, the
odds ratios estimated by logistic regression
will differ markedly for the surrogate and
the true exposure measure, while much less
bias will occur when correlations between
the two measures are 0.8 orgreater. In vivo
tibia lead levels measured by X-ray fluores-
cence have been proposed as a good surro-
gate for cumulative blood lead levels on the
basis of a correlation coefficient of 0.84
(9). For dietary exposures, however, the
correlation between food frequency ques-
tionnaires and less error-prone methods
(food records, measurements in food or
biological samples) is onlyaround 0.5 (10);
yet food frequency questionnaires continue
to be applied in large-scale studies, only
occasionally with correction of risk esti-
mates for error in measurement. On the
other hand, the failure to find a correlation
(actual coefficients not given) between cur-
rent adipose tissue or serum dioxin levels
and surrogate measures ofpast exposure to
Agent Orange in Vietnam (11,12) affected
a decision not to conduct further research
using exposure surrogates based on troop
location and herbicide spraying records.
These examples underscore the need to be
explicit about criteria for acceptable surrogate
measures, as well as the need to take error
into account when surrogates are used, even
while emphasizing the development ofbetter
approaches toexposure-dose assessment.
In the following section, we describe meth-
ods designed to reduce error in exposure mea-
surement insofar as is currently possible
(approaches such as dosimetric modeling,
pharmacokinetic modeling, biologic markers,
and use of multiple measures), as well as
approaches to assessing the residual uncertain-
ties in theestimateddose. Even thebestofthe
current methods will not yield a measure that
is completely error-free, and it is therefore
important to recognize and characterize the
residual errorin measurement so that it can be
consideredinanalysisofthedata.
Measurement Approaches
Exposu orDoseModding
Estimating a subject's exposure to an envi-
ronmental agent involves combining infor-
mation about possible sources of exposure
(usually obtained from the subject, from
some other respondent, or from records)
with an assessment of the likely degree of
exposure from each source.
When an exposure under study is envi-
ronmental, there may be multiple pathways
by which a person might be exposed and it
can be important to consider all elements
and all routes. For example, residents
downwind of the Nevada Test Site could
have been exposed to external gamma radia-
tion from the passing fallout cloud itself,
from ingesting contaminated milk or
vegetables, or, in the case of infants, from
in utero exposures or breast-feeding. For
each of these pathways, several different
radionuclides might need to be considered.
After eliminating pathways that would be
expected to make a negligible contribution
to the total dose, one can estimate the
likely dose rate per unit ofexposure to each
pathway. In the fallout example, this
involved consideration of a) source term,
the amount and type of radionuclide
released; b) the environmental transport,
dispersion from the source to sites ofdepo-
sition; c) rate ofradioactive decay and envi-
ronmental dispersion of the radionudides;
d) farm management practices leading to
contamination ofdairy cattle or vegetables;
e) estimates ofthe uptake ofradionudides
by vegetables and milk; f) distribution of
milk and vegetables to consumers; and g)
uptake by the target organ from ingested
radionuclides. To calculate an individual's
dose, this information was then combined
with extensive questionnaire data on breast-
feeding and maternal and individual con-
sumption ofmilk and vegetables at various
ages. For some subjects, modifications
were needed to allow for homegrown veg-
etables or backyard cows or goats. For sub-
jects with incomplete exposure information,
distributions ofdefault values specific to their
particular circumstances (age, sex, location,
etc.) were developed. Similar calculations
were performed for each ofover 100 nudear
tests, and the results then were summed to
produce estimates of each subject's total
dose (13).
The process described above is far more
complex than has been the norm in envi-
ronmental epidemiology, but it represents
the current state ofthe art in environmen-
tal dose assessment. Less refined, but per-
haps less costly, approaches to exposure-dose
modeling (often for households or geo-
graphic areas rather than for individuals)
have been based on Gaussian-dispersion
modeling of airborne emissions (14-16),
hydrogeologic modeling of waterborne
exposures (17), and isopleth modeling of
soil contaminants (18). Assuming that
dosimetry models are reasonably accurate,
such approaches should decrease bias aris-
ing from measurement error and increase
precision. Assessment of the validity of
dosimetry models should be made whenever
possible. Forexample, an environmental dis-
persion model ofemissions at the time ofthe
accident at the Three Mile Island nuclear
plant was validated by the readings from
off-sitethermoluminescent dosimeters.
Dosimetric modeling methods are likely
to be used more frequently in future envi-
ronmental health studies. A question is
whether the effort required both in terms of
the information that must be collected from
studysubjects and/or byenvironmental sam-
pling and the effort involved in development
ofthe dosimetric model itself are warranted
by the gain in precision or reduction in bias
of the exposure estimates. Information on
this point could be obtained by comparing
the point and interval estimates of associa-
tions observed using gold standard dose esti-
mates with those that would be obtained
using cruder methods. Such comparisons
could be made in existing data sets.
Understanding when the gains from dosi-
metric modeling are substantial and when
they are only marginal would be useful in
establishing methodologic standards of
practice.
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Some other issues related to dosimetry are
exemplified by studies ofcancer and electric
and magnetic fields (EMFs). The initial
hypothesis about EMFs was derived from
observations showing apparent excesses of
leukemia (and some other cancers) both in
children living near electric power lines that
would be expected to generatehigh magnetic
fields (19) and in certain dasses ofelectrical
workers (20). In both the residential and
occupational settings, it has been difficult to
establish whether the magnetic fields are the
responsible agent. While subsequent studies
have demonstrated that certain electrical
wiring configurations and certain categories
ofelectrical work are associated with higher
than average fields, so far no convincing asso-
ciations have been found between leukemia
risk and individuals' exposure to electric or
magnetic fields determined by area measure-
ments. No studies using personal dosimetry
haveyet been reported.
Four possible explanations are suggested
for the failure to establish a clear associa-
tion between cancer and measured field
strengths. First, it may be due to their
extreme variability in space and time. Any
necessarily short-term measurement (24 hr
or aweek in a small number oflocations) is
a poor surrogate for lifetime dose; under
this explanation, household wiring classifi-
cations and job titles may be more stable
measures of long-term exposure. Second,
the failure to detect an association with
measured fields may reflect a failure to
measure the biologically relevant parameter
(e.g., peaks, transients, resonance between
static and oscillating fields rather than the
time-weighted average). Studies of repro-
ductive outcomes, where the period of
exposure is much shorter than for cancer
and where there may be a particular time
window of vulnerability, could help indi-
cate whether the discrepancy in associa-
tions with wire codes and measured fields is
due to their capturing different time frames
or different dimensions of EMFs. A third
explanation for the associations of cancer
with wiring configurations, but not with
measured fields, relates to selection bias
(lower selection probabilities for controls
living nearwiringwith high current config-
urations). Fourth, the surrogate exposure
measures (wire codes, job titles) may be
confounded by other correlated risk fac-
tors. This controversy is still far from
resolved, but consideration ofselection bias
and possible confounders together with
careful assessment of all potentially salient
aspects of electric and magnetic fields and
of the variability of the different measure-
ments should shedlight on the issue.
The EMF example underscores the need
for making multiple measures ofexposure.
In particular, it argues for continuing to
indude surrogate measures along with gold
standard measures in studies of health
effects until the relations between the sur-
rogate and criterion measures are well
understood and there is certainty about the
true gold standard (i.e., until the correct
biologic mechanism is known). Substituting
an incorrect gold standard for a surrogate
measure can actually increase measurement
error. One analytic approach to using
multiple measures that has been proposed
as a means of increasing validity is to
restrict analysis to subjects who are classi-
fied as exposed or unexposed by two differ-
ent, if imperfect, exposure measures (21).
This dearly risks some loss in power since
subjects with discordant results on the two
measures are excluded from analysis.
Another proposed approach is to estimate
the misclassification probabilities for each
measure and from them to estimate the
prevalence ofexposure (22).
Some mention of personal monitors
should also be made. While these do not
provide a measure ofresulting body burden,
as biologic markers are meant to do, per-
sonal monitors may measure the intensity of
an individual's total exposure to airborne
agents better than fixed-site area monitors.
This is not always the case, however, partic-
ularly in studies oflong-term exposures or
where areawide concentrations are fairly
uniform. The TEAM study (TotalExposure
Assessment Methodology) conducted by the
U.S. Environmental Protection Agency
(EPA) found thatpersonal air monitorswere
acceptable to subjects from 7 to 85 years of
age (23). Investigators studying effects of
exposure to EMFs and indoor air pollu-
tants on children are anxious to develop
personal monitors that can be used with
children under age seven, including tod-
dlers. At present, personal monitors for
EMFs are in the form of wristbands and
may not be suitable for very young chil-
dren. Technology for personal exposure
monitoring is still evolving, but it will
rarely be feasible to apply personal expo-
sure monitoring to all subjects and all rele-
vant time periods. Therefore, methodologic
approaches are needed for combining col-
lected exposure datawith personal samplers
and environmental monitors.
PharmacokineticModeling
Pharmacokinetic modeling is an approach to
dosimetry that incorporates information
about the internal pharmacologic processes
that ensue once an agent reaches theportal(s)
of entry into an individual's body (24).
These include uptake into the circulation;
distribution within the body; and metabo-
lism, storage, and elimination. These mod-
els can be simple, involving only one body
compartment, or complex, involving mul-
tiple body compartments. In either case,
compartmental rate relationships are used
in the model's equations to estimate con-
centrations at critical tissues. Such models
are also useful as guides to temporally rele-
vant and efficient ambient sampling (24).
Pharmacokinetic modeling ofexposure and
dose may be viewed as a counterpart to
biologically based disease models.
BiologicMarkrs
Because of the difficulty of obtaining accu-
rate and unbiased exposure information
from studysubjects and the difficultyofesti-
mating the doses that such exposures might
produce, there has been great interest in the
development of biologic markers. These
may be defined as "cellular, biochemical, or
molecular alterations that are measurable in
biological media, such as human tissue, cells,
or fluids" (25). If used appropriately, bio-
logic markers allow for considerable
improvement in measurement of dose.
First, they may obviate the errors arising
from subjects' lack of knowledge, memory
failure, biased recall, or deliberate misinfor-
mation (26). Second, even when subject
reports ofexposure are accurate, individuals
may vary considerably in uptake and han-
dling ofa material; the error introduced by
such individual variation can be reduced or
removed by using markers that provide an
estimate ofthe dose to a particular individ-
ual. Third, some markers can be used to
detect biological interactions between the
exposure of interest and critical tissues;
DNA adducts are an example ofthis type of
marker. In studying environmental tobacco
smoke, for instance, one can-in addition
to asking about maternal smoking during
pregnancy-actually measure smoking-
related DNAadducts in placentae (27) and,
where the fetus is lost, in critical organs such
as fetal lung or liver (28). Another advan-
tage of biologic markers is that generally
they give a quantitative, or at least semi-
quantitative, estimate of dose. They also
can serve as the gold standard for other
information sources, thus providing a basis
for error allowance procedures in studies
that rely on less accurate exposure measures
due to the cost ofthe marker.
OtherBiologicDosimeters
Certain signs or symptoms can also be
viewed as biologic dosimeters. For example,
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in the cohort ofatomic bomb survivors, it
has been reported that subjects with a his-
tory of epilation have a 2.5-fold steeper
dose-response curve for leukemia than
those without (29). This can be inter-
preted either as an indicator oftheir greater
radiosensitivity or as an indicator ofmises-
timation oftheir doses, perhaps as a result
ofdifferences in shielding not accounted for
byavailable dosimetry data.
To be useful in environmental epidemiol-
ogy studies, a biologic exposure marker
should be dearly better than anamnestic data
or environmental measures; should allow for
differentiation between exposure levels;
should be applicable on alarge scale; or iftoo
costly for large-scale use, should at least be
acceptable to subjects in a validation sub-
study. Before markers are used in epidemio-
logic research, their sensitivity and specificity
should be known from both the laboratory
and epidemiologic perspectives; reproducibil-
ity ofresults within and between laboratories
must also be known; and, very importantly,
theparticular time frametheyreflectanddur-
ingwhich they can be measured in vivomust
be established (25) so that they provide
interpretable dataregarding timeanddose.
At present, few exposure markers satisfy
these requirements. Some markers may pro-
vide a record of cumulative exposure (e.g.,
bone lead measurement, mercury or cocaine
measurements in hair), but most can assess
only relatively recent exposures. Studies of
biologic markers that use a case-control
design and a cross-sectional marker ofexpo-
sure can be difficult to interpret because of
ambiguity about the temporal sequence of
the marker and the disease [e.g., whether
selenium levels in breast cancer cases are
cause or consequence (30)]. Indeed, such
studies can be misleading. Vineis and
Caporaso (31) have described how a
case-control study nested in a cohort
allowed Wald and his colleagues (32) to
make use ofthe time between initial collec-
tion of specimens from members of the
cohort and subsequent onset of cancer to
darify the time order in the relationship with
blood retinol. Although analysis considering
only the early cases ofcancer suggested that
blood retinol might be protective, ultimately
it was apparent that some metabolic change
associated with the disease was acting to
reduce retinol levels, rather than vice versa.
In addition to such problems in interpreta-
tion, biological measurements are often
costly to perform. Furthermore, the need to
obtain specimens can reduce the cooperation
ofsubjects and introduce the potential for
selection bias to occur through initial refusal
or later attrition, although these problems
are probably not insurmountable ifthey are
anticipated and addressed.
UseofMultipleMeasu
When the biological basis ofan association
is poorly understood, it can be very helpful
to have various types of exposure measure-
ments available. Or, as mentioned previously
in connection with personal exposure moni-
toring, it may be necessary to relyon another
source of exposure information for portions
ofthe studyperiod. The obvious approach is
to analyze each type of measurement sepa-
rately, but there may be merit in combining
them into an index, ifonly to reduce mea-
surement error. Complications can arise ifall
measurements are not available on the same
subjects. Any associations observed might be
due to differences in the measurements or to
differences in the subgroups ofsubjects for
whom the measurements are available. In a
study ofchildhood leukemia and electric and
magnetic fields, London et al. (33) reported
the results separatelyforvarious summaries of
24-hr bedroom dosimetry, spot measure-
ments atvarious locations, andwiringconfig-
urations. However, drawing on all ofthese
data, they also developed regression models
for magnetic fields at various locations based
on attributes ofthe wiring and used the val-
ues predicted by these models as the time-
weighted average fields for all houses lived in.
Thus, predicted values were used both to
replace existing measurements and to impute
missing values. The rationale behind the
approach is to avoid the loss ofinformation
and possible selection bias associated with
restricting analysis to subjectswithdataforall
measurements made (34). One alternative is
to retain measurements where they exist and
to impute only the missing values, leaving
open the possibility ofstratifying on data
quality in the analysis. Other approaches
undoubtedly can be devised, and it would be
desirable to compare their validity using data
sets in which exposure-response relationships
are well understood and where more than
onemeasureofexposure exists.
Other Issues in Measurement
of Exposure
TakingAccountofCriticalPeriods for
Exposure
A principal problem in environmental epi-
demiology has been that the inaccuracy in
measurement generally (although not
always) operates in the direction ofoveres-
timating exposure and therefore underesti-
mates risk or perhaps misses health effects
altogether. For example, when assigning
the same level ofexposure to all 1000 resi-
dents living within five miles of a toxic
dump site when only 100, say, were truly
exposed and the other 900 were either unex-
posed or exposed at very low levels, one
would be certain to calculate an observed
relative risk for exposure that would be
lower than the true risk. Hence the impor-
tance ofincreasing the accuracy ofexposure
definitions and measurement is obvious.
Rothman and Poole have pointed out (35)
that it is also important to use information
on critical periods for exposure, either in
the design phase ofa study, in the analysis
phase, or in both. For example, in a study
of Down's syndrome, parental exposures
occurring after the fertilization period are
presumably irrelevant to the outcome; in
fact, there is mounting evidence that most
cases of Down's are traceable to errors at
the time ofthe first meiotic division in the
maternal germ cell (36). By removing all
exposures that are not of biologic conse-
quence from the estimate of association,
one can expect the magnitude of the esti-
mated association to increase. Moreover,
information on known critical periods
might be used to test whether an associa-
tion appears to be spurious. If an associa-
tion were found not only during the critical
period butalso forexposure duringnoncritical
periods, then the association might be due to
recall bias, or itcouldbereflectingautocorrela-
tions in exposure status. Multivariate analysis
ofthe effects ofexposure in various critical and
noncritical periods could, in principle, over-
come this problem, provided there are enough
exposed subjects with different temporal
patternsofexposuretobeinformative.
TakinAccountofMirationInand
OutofxpsdAreas
The problem of in- and out-migration is
frequently raised as an issue in interpreting
results of studies that define exposure in
terms of time and place. Although several
studies have considered the effects ofpopu-
lation migration on the validity and preci-
sion of estimated associations between
exposure and disease (37) andhave described
when and in what direction bias is likely to
arise, these issues are still not understood
well. Perhaps more simulations or empiri-
cal demonstrations are needed to improve
the general level of comprehension about
the effects of population mobility on geo-
graphic studies. In the case of specific
studies, it would help to know something
about duration of residence or at least age-
specific duration patterns in an area. One
recent suggestion is to estimate by various
means the fraction (f) of time spent by a
subject in a particular place and to assign for
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the remaining fraction (1-f) the average
exposure forsometotal referent area (38).
A ingPastEPosun
A major problem in many environmental
health studies is the difficulty ofestimating
past exposures when only present-day mea-
surements are available. Often, some data on
subjects' past exposures can be obtained by
questionnaire or review ofexisting records.
For example, in occupational studies, payroll
records are used to assemble a job history.
Theuseofrecords fromyearspasttoestablish
exposure status has the important advantage
ofobviating recall bias, although itmayintro-
duce its own problems (e.g., missing records
or less specificity in records from earlyyears).
Estimating the actual historical exposure lev-
els is more difficult than simply classifying
exposure status, and it often involves a large
degree ofjudgment. Clearly, the more his-
torical data there are on variation in exposure
levels over time and place, the better. Study
ofsuchpatterns ofvariation cansuggestmod-
els forpredicting exposures attimes forwhich
no measurements are available. For example,
in a study ofsalivary tumors and dental X-
rays, Preston-Martin et al. (39) reviewed 58
studies that described doses from various pro-
cedures at various times and, while taking
into account the dates ofintroduction ofnew
technologies, used regression analysis to
develop models for the expected dose as a
function ofcalendar year. In occupational
settings, the subjective experience oflong-
service workers has been used to compare
current exposures with those in the distant
past. Similar strategies (i.e., tracking techno-
logical developments, use ofknowledgeable
informants) need to be applied in the assess-
ment ofpast environmental exposures. For
example, in a case-control studyofcolorectal
cancer andwater chlorination amongwomen
teachers in New York State, Lawrence et al.
(40) used currentwatersamplinginconjunc-
tionwith records fromwatertreatmentplants
covering the previous 20 years in a mathe-
matical model to estimate cumulative expo-
sures to chloroform in drinking water at
homeandatwork.
Uses ofEisting
One limitation on assessing past environ-
mental exposures is that reviews ofexisting
data bases at the national and state level
srepeatedly have found them to be inade-
quate for epidemiologic purposes because of
insufficient data points to assess variability, lack
ofa standardized QualityAssessment/Quality
Controlprotocol, incompletegeographic cover-
age, and missing information (41). Efforts
are underway to modify the major air and
water data bases to make them more useful
for future environmental health studies.
Existing environmental data banks could
also be used to define strata within which
to conduct sample surveys. Surveys of
individualswithin these ecological exposure
groupings would help document human
activity patterns and could indicate the dis-
tribution of exposure and important con-
founding or effect-modifying variables in
each stratum. Potentially, such stratified-
sample surveys might provide the basis for
constructing an environment-exposure
matrix similar to thejob-exposure matrices
used in occupational studies. Such expo-
sure matrices are generally assumed to have
a "Berkson error" structure (42), in which
the average ofthe true doses for all subjects
in an exposure assignment group is equal
to the assigned value. As a consequence, if
the true dose-response is linear, the esti-
mated slope ofa linear relationship will not
be biased toward the null.
Estimating Dose Uncertainties
A major concern among environmental epi-
demiologists is the influence oferrors in expo-
sure estimates on associations with disease and
methods ofdalingwithsucherrors. The best
cure for this problem is to avoid measurement
errorin the firstplace. Whenthis is notfeasi-
ble (and it often may not be, particularly in
investigating common source exposures such
as toxic dump sites), it is helpful to be able to
quantify the direction and magnitude ofthe
errors. This can bedoneinanumberofways,
induding a) validation studies on a subset of
the studysample orapilotsample to compare
the measurements to bemade in the fieldwith
a gold standard, b) replication ofmeasure-
ments to assess within-subject variability, c)
multiple types of measurements to assess
validity, and d) sensitivity analysis to esti-
mate the influence ofvarious unknowns or
uncertain parameters on the estimated
doses. The goal might be either to describe
the distribution of exposure errors across
the population (or subgroups there of) or
to obtain an estimate of the precision of
eachsubject's exposure assignment.
Because a gold-standard assay is often not
feasible for use in the field (because ofcost,
time, acceptability, etc.), validation studies
usually must be limited to a relatively small
numberofsubjects. Theresultingestimates of
error distributions may be imprecise (43),
although this will be less ofa problem ifthe
data are treated as continuous and ifparame-
ters for sensitivity and speificity do not have
to beestimated (8). Nonetheless, samplesizes
forvalidation studies that are needed to insure
good estimates ofthe error rates in field mea-
surements should be calculated carefully.
Other considerations are to insure that the
measurementerrorprocess inthesample used
forvalidating the field measure is similar to
that in the target population for the full
study and to avoid selection bias in the vali-
dation study, which might arise if require-
ments associated with use of the gold
standard measure are very demanding and
participation rates are consequently low. In
the New Jersey case-control study of radon
and lung cancer among women, in-home
radon measurements were obtained for only
40% of the houses targeted, and smoking
rates differed among those with measured
and unmeasured homes, raising the possibil-
ity ofselection bias (44). Ifdata on disease
are collected on validity study participants,
potential selection bias can be examined by
testingforheterogeneityin theriskestimates.
Replicate measurements are useful for
describing repeatability (45) but cannot
assess othercomponents oferror, such assub-
jects' tendency to consistently overreport or
underreport exposures. Having different
types ofmeasurements available maybe more
useful in estimating misdassification proba-
bilities, even ifnone ofthe measures is error-
free. See, for instance, Hui and Walter's
maximum likelihood method for estimating
error rates with two independent assessments
ofexposure (22).
Sensitivity analyses can take a number of
forms. The basic idea is to consider a range
ofplausible values for each ofthe unknowns
in the exposure assignment process. Ifthere
areonlyafewunknowns, onemightconsider
each ofthem and evaluate their influence on
either the individual exposure assignments or
the final dose-response relation. Ifthere are
many, one can estimate the distribution of
assigned doses, either analytically or by
MonteCarlo simulation. Thelatterapproach
was used in the studies around the Nevada
Test Site because of the complexity of the
dosimetryalgorithm. Components ofuncer-
taintythatwereconsideredindudethesource
term, environmental transport, farming prac-
tices and distribution, and default values for
individuals' missingdata. Aseries ofsensitiv-
ity analyses were also carried out on a mathe-
matical model that estimated the relative
geographic distribution ofexposure to acci-
dentemissions atThreeMileIslandbyexam-
ining variations in modeling assumptions for
theireffect on the base case (46). Parameters
considered were the source term, the degree
ofplume rise, wind shifts, and residual error
weighting. In addition, a Bayesian analysis
was used to quantify uncertainty about the
time-release pattern.
Environmental Health Perspectives Supplements
Volume 101, Supplement4, December 1993
53HATCHAND THOMAS
Measuring Outcome of
Environmental Exposures
Ddeinitioa Iues
As strong effects ofenvironmental exposure
have been identified and dealt with, envi-
ronmental epidemiology increasingly has
become a search for weaker associations. It
is all the more important, therefore, to
improve measurement of outcome through
careful definition and avoidance or reduc-
tion of error (35). In defining study end
points, the aim should be to specify the
health outcome of interest as precisely as
possible in order to avoid further dilution
of a weak association through inclusion of
irrelevant cases. In fact, it may be desirable
to consider subgroups of disease that are
etiologically homogeneous and that are
believed to be responsive to the exposure of
interest on the basis of theory or prior
observations (e.g., certain histopathologic
types of lung cancer and radon; leukemia
types and subtypes with ionizing radiation
and EMFs). This can present something of
a dilemma, however, because statistical
power for examining subgroups is likely to
be low unless the difference in effect size
among subgroups is sufficient to offset the
reduced sample size.
The virtues of lumping versus splitting
frequently come up for discussion in the
context ofstudies ofcongenital anomalies.
It is unlikely that an exposure would affect
all types ofcongenital defects. With mater-
nal cocaine use during pregnancy, for
example, defects involving vascular disrup-
tion seem to be implicated. However, a
biological basis for positing subgroups of
interest is often lacking; empirical Bayesian
approaches may be useful in helping to for-
mulate relevant subgroupings. In any
event, the numbers in particular case
groups are likely to be small for all but a
few categories. If sufficiently large series
cannot feasibly be accrued in a single study,
multisite (even multinational) projects may
need to be mounted, or more reliance may
need to be placed on meta-analyses com-
bining results from several studies. Which
of these strategies to pursue should be dis-
cussed by groups of investigators studying
the same exposure, and their potential
funding sources.
Disease outcomes in environmental epi-
demiology can be measured on a continu-
ous scale or categorically as incident or
prevalent cases or as deaths. Incidence data
are usually preferable for investigating eti-
ology since prevalence or mortality data
may be influenced by factors affecting
duration of disease and survival as well as
those relating to cause. However, inci-
dence data are often less easily accessed
than mortality data, and they can be sub-
ject to artifactual variations in ascertain-
ment-as a result of screening programs,
for example. Whether incidence or mortal-
ity is the more reliable indicator of health
status and in what age groups it is reliable
have been discussed extensively but not
resolved. See, for example, the recent
papers by Doll (47) and by Davis et al.
(48) about cancer time trends. It might be
helpful to have a set of recommended
approaches for trend analysis that were
developed by a group of dispassionate
methodologists. For etiologic studies, inci-
dence data seem conceptually superior;
when mortality data are used, considera-
tion needs to be given to accounting for
influences on survival since these might
correlate with exposure.
In some areas ofresearch, such as repro-
duction and development, different out-
comes can occur depending on the timing
and dose of exposure. In such circum-
stances, it may be important to examine
several end points. Extending population-
based registration systems to cover more
outcomes than cancer and birth defects and
to cover more geographic areas potentially
could be useful for environmental studies in
several respects: in identification ofcases, in
validation of self-reported information, and
in ascertaining disease status ofmigrants.
BiologicEffectMarkers andOther
EarlyIndicators ofDiseaw
Biologic effect markers potentially have a
number ofadvantages as study end points,
particularly if they are strongly prognostic
of disease in ways not explained by avail-
able exposure information-for example,
by reflecting susceptibility or the action of
cofactors (26). While some effect markers
are actually subclinical events (e.g., bio-
chemical tests of occult pregnancy loss),
often markers of effect correlate only
weakly with disease. Serum alpha-fetopro-
tein is a useful marker for liver cancer as
well as a prenatal marker for neural tube
defects. Markers that are not as clearlypre-
dictive ofrisk, particularly at the individual
level, can lead to problems ofinterpretation
and to needless anxiety for those individu-
als found to have elevated levels. The pre-
mature application ofapoorlystandardized
cytological assay on a group ofalready con-
cerned residents at Love Canal is a case in
point. Calls have been made repeatedly to
carry out longitudinal studies, in experi-
mental animals and humans, that will mea-
sure the positive predictive value of such
markers before applying them in field stud-
ies; but these have been largely ignored.
The Scandinavian countries, however, have
mounted a collaborative prospective study
of cancer in a cohort of 3190 individuals
who have been tested for sister chromatid
exchanges (SCEs), structural chromosome
aberrations, or both. A report based on a
13-year follow up of 800 subjects in the
Finnish portion of the data (49) found a
moderate, statistically significant positive
association between cancer risk and chro-
mosome aberrations (SMR = 2.65; 95% CI
1.2, 5.0); there was a positive trend (SMR =
2.06; 95% CI 0.8, 4.2) for SCEs. Additional
prospective studies ofthis kind are needed to
establish the relationships between markers
and disease in order to assure their appro-
priate use and interpretation. In addition,
determining when a marker could serve as
the basis for preventive health measures
directed at a distal end point such as cancer
is an important issue; see Prentice (50) for
a useful discussion of this and a proposed
operational criterion for surrogate response
variables.
Other potential advantages of biologic
effect markers are their use in classifying
disease more precisely and in suggesting
mechanisms of action, such as those relat-
ing to susceptible subpopulations. For
example, biologic markers that distinguish
slow from fast acetylators have indicated
that the enzyme N-acetyltransferase plays
an important role in bladder cancers
induced by exposure to aromatic amines
(51,52). Methodologic needs in the area
of effect markers include attention to
sources of variability, both biological and
laboratory-related, and to logistical issues,
such as how to achieve reasonable partici-
pation rates when the effect marker requires
ademanding regimen. Three current studies
of early pregnancy loss illustrate this latter
problem. Two ofthe studies askparticipants
for daily urine samples. The third study
uses a modified specimen collection scheme
requiring urine samples only twice
monthly, at the beginning of menses.
Preliminary data indicate higher response
rates for the study with the simplified col-
lection protocol. Whether the variability
in enrollment is due to the differing
demands on studysubjects or to other vari-
able aspects ofthe three studies (such as the
perceived salience ofthe topic in the target
population) is not known. Systematic
research is needed to determine how to
achieve cooperation in studies that use bio-
logic markers andhow to provide for calcu-
lating or estimating the extent and
magnitude ofselection bias.
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Subdinical EndPints
What role should physiologic changes (e.g.,
nerve conduction velocity, T-cell subsets,
sperm count) have in environmental health
assessments? It has been argued that func-
tional alterations and nonspecific symptoms
arelikely to be more frequent consequences of
low-level environmental exposures than
frank disease (53). However, baseline rates
and normal ranges for such end points may
be lacking. Objective methods of assess-
ment to remove the potential for biased
recall may be at an early stage of develop-
ment, and interpretation ofresults in terms
of risk to groups and to individuals fre-
quendy is problematic, particularly as assay
improvement allows for discriminating
function more and more minutely. These
methodologic limitations can be addressed-
semen evaluation is a case in point (although
the clinical significance of altered semen
quality is still not clear-cut)-however,
substantial time and effort will be required.
Measuring Confounders and
Effect Modifiers
Effect on Risk Esima if
Indequatel Controlied
Aconfoundingvariable is one that, ifnot con-
trolled appropriately, will tend to distort the
exposure-disease association. For example,
when studyingwhether household exposure to
radon is a cause oflung cancer, one should be
concerned about the possible confounding
effect ofsmoking. Smoking is dearly a major
riskfactorforlung cancer. Ifhouseswith high
radon levels are more likely to be inhabited by
smokers, then this would produce an apparent
relationship between radon and lung cancer
even ifthere were no causal effect. The con-
verse also could happen; ifsmokers tended to
live in low-radon houses, then one might fail
to find an association between radon and lung
cancer ifit really were present.
The strategies commonly used by epi-
demiologists to control confounding indude
restriction (e.g., to nonsmokers), matching,
or statistical adjustment. All of these
approaches presume that the confounding
variable has been correctly measured.
Greenland (54) has pointed out that errors
in measurement of a confounding variable
will tend to cause partial loss of an ability
to eliminate confounding bias; for example,
ifthe true odds ratio (adjusted for the true
confounder) is 2.0 and the crude odds ratio
(unadjusted) is 4.0, then the odds ratio
adjusted for an incorrectly or crudely mea-
sured confounder might be 3.0. This
intermediate outcome can only be counted
upon in a case in which the errors in mea-
suring the confounder are random (unre-
lated to exposure or disease status); in other
cases, the adjusted odds ratio could be fur-
therfrom the truth than the unadjusted odds
ratio. Kupper (55) has shown that an inac-
curate surrogate confounder can produce
seriously misleading inferences.
A factor like smoking, in addition to
being a confounder, could also act as an
effect modifier-that is, a variable that
modifies the strength of the association
between exposure and disease. A major
question in the radon literature is whether
the joint effects of smoking and radon
exposure are multiplicative, additive, or
some intermediate possibility. If they act
additively, for example, then radon expo-
sure would produce the same additional
risk of lung cancer in smokers and non-
smokers; but because lung cancer is rare in
nonsmokers, it would follow that radon
exposure might account for a much larger
proportion of lung cancers in that group.
Conversely, ifthe two exposures act multi-
plicatively, the proportional increase in
lung cancer rates due to radon exposure
would be the same in smokers and non-
smokers; but because of the higher rates in
smokers, the absolute increase would be
larger in smokers. This issue therefore has
important risk assessment and public health
policy implications. Again, Greenland (54)
has shown that errors in measurement of a
covariate can distort its modifying effect
and possibly introduce an apparent interac-
tion where none exists. Diet and cooking
habits in relation to aflatoxin exposure, and
showering habits in relation to radon are
additional examples ofpotentially important
confounding or effect-modifying variables in
environmental epidemiology.
Approaches to Measuring Common
Confounders andModifiers
The implications of the previous section
are that careful measurement ofstrong con-
founders or modifiers should be given as
much attention as the exposure and disease
variables. It follows that some ofthe same
approaches discussed in the sections on
measurement ofexposure and disease, such
as use of multiple measures and biologic
markers, will pertain here as well.
Continuingwith the example ofsmoking,
it is not sufficient simply to classify subjects
by their present status as current, former, or
never smokers. As long as smoking is a risk
factor for the disease under study, one usu-
ally tries to obtain information on at least
the ages at starting and stopping and the
average daily amount of smoking. These
data can be used to compute pack-years (the
product ofamount and duration), which is
a stronger predictor of lung cancer risk
than current status. In some other cases,
however, such a product term may actually
increase error. Better yet, nonlinear multi-
variate models could be used to allow for
the joint effects ofage at starting, duration
and intensity of smoking, and time since
quitting. Other modifying factors might
include changes in level of smoking over
time, use of filter cigarettes, and depth of
inhalation. However, incorporating multi-
ple modifying factors into an analysis needs
to be done with considerable thought to
produce models that are biologically plausi-
ble. Routine inclusion ofinteraction terms
in a multiple logistic regression analysis can
produce models in which ex-smokers even-
tually become at lower risk than never
smokers, or light smokers have the same
dependence on duration or age at start as
heavy smokers. Use of general risk models
based on biologically plausible theories is an
attractivealtemative.
Even the most complete smoking history
is still likely to be misclassified, and the
errors might well be related to the exposure
or disease variables under study. In an
occupational study of radon exposure and
lung cancer, for example, miners with lung
cancer might preferentially underreport
their smoking histories to avoid prejudicing
a compensation claim. For these reasons,
there has been great interest in developing
unbiased methods of assessing potential
confounders. Biological measures, such as
urinary cotinine for smoking or 4-amino-
biphenyl-DNA adducts, are very attractive
for this purpose. Other approaches were
discussed above, in the section on exposure
measurement. The disadvantage of most
ofthese methods is that they measure only
recent exposure and lifetime exposure will
still be misclassified. The development of
methods for combining information from
different types of measurements could be
very useful. Also discussed previously in the
exposure measurement section, and equally
relevant here, is the need to assess and
allow for measurement error in con-
founders and effect modifiers whenever
possible. Therefore, consideration should
be given to mounting validation substudies
to quantify measurement error in important
covariates.
Suscptibiity
Variation within a population in sensitivity
to an exposure of interest can be substan-
tial. Khoury et al. (56) estimated the pro-
portion of susceptible individuals in the
population for cigarette-induced cancers at
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several sites; the proportions varied from
<1% for oral and esophageal cancer up to
13% for cancer of the lung. Bias in risk
estimates will arise ifindividuals with simi-
lar exposures but different susceptibilities
are treated the same. There are a number
ofepidemiologic designs for assessing sensi-
tivity to environmental exposures. As a
measurement problem, the central issue is
whether the markerfor sensitivity beingexam-
ined is a measurement ofthe genotype itsef,
somehostcharaceristic, orfamilyhistory.
The ability to classify genotypes directly
has profound implications for identifying
sensitive individuals. The obvious diffi-
culty is that there are millions of genetic
loci, for which only a relatively small num-
ber have probes available and only a few
might be relevant to any particular disease.
Thus, some prior knowledge that a locus
has a role in the disease process is essential
before embarking on a search for interac-
tions with possible environmental expo-
sures. Even so, theinformationforidentifying
genetically susceptible individuals may
involve invasive and costly tests.
Recognition ofphenotypically distinguish-
able subgroups of the population that have
different baseline risks ofdisease or sensitivi-
ties to environmental exposures can therefore
be very useful for public health protection.
The measurement issues that arise here are
essentially no different from those for any
othereffectmodifier, asdiscussedabove.
For family history as a marker ofsuscep-
tibility to a disease, the basic minimal
information that needs to be collected is
the identification of the family members
with the disease and the number, ages, and
relationships of family members at risk.
This information should be collected sys-
tematically for all first-degree relatives (par-
ents, siblings, and offspring), and possibly
for all second-degree relatives. As the
objective is to examine family history as a
marker of sensitivity to an environmental
exposure, every effort should be made to
obtain exposure information on all relatives,
notjust theaffected ones.
oschial Stress as Confounder,
Modifier~, andMediator
The psychosocial stress that may be associ-
ated with exposure to a perceived environ-
mental hazard can potentially confound,
mediate, ormodifyanyassociations between
the exposure and disease. Stress might
operate indirectly and cause exposed indi-
viduals to alter risk behaviors. Stress also
could have an artifactual association with
the end point ofconcern because ofchanges
in care seeking, diagnostic practices, or self-
reported health states. Alternatively, con-
cern about environmental exposures could
cause adverse outcomes other than those
potentially associated with the perceived
hazard. For example, studies around the
Three Mile Island and Chernobyl nuclear
plants indicate that the perception ofdan-
ger can increase distress levels or clinical
states like anxiety and depression (57,58),
irrespective of whether radiation-induced
increases in cancer actually occur.
The issue ofstress as a confounder, effect
modifier, mediator, indicator of some
methodologic bias-or even as an exposure
oroutcome-needs tobeexplicitly addressed
in future environmental epidemiologic
research conducted on sensitized popula-
tions. Some relevant methodology has been
developed in studies of communities near
toxic wastes to distinguish between biologic
effects ofexposure to hazardous substances at
such sites and either symptoms of stress or
altered symptom reporting (59,60). These
preliminary efforts indude use of a scale to
measure hypochondriasis and stratified
analysis ofself-reported symptoms to take
account of subjects' perception about the
source of pollution. Environmental epi-
demiologists need to learn when and how to
address the issue of psychosocial stress in
order to clarify interpretation of health
effects studies and to estimate the importance
of stress in its own right. Consideration
should begiven to measuringperceived stress
and physiologic indicators ofstress as well as
to collecting data on methodological
covariates such as motivation to participate,
interest in receiving health care, and beliefs
about the exposure in question as a cause of
adverse health effects.
Methodologic Needs and
Recommendations
The aspect of study design that involves
measurement ofvariables is critical, espe-
cially in fields like environmental epidemi-
ology where the risks from exposure are
likely to be small, difficult to detect, and per-
haps not dinically significant, yet may be of
public health importance. Methodologic
research in this area should emphasize the
further development and application of
dosimetric modeling. Existing data sets rep-
resenting a range ofresearch problems within
environmental epidemiologycould be used to
assess the gains from dosimetry algorithms
compared with cruder, more conventional
methods ofexposure assessment.
Dosimetry models invariably will use a
combination of questionnaire data, envi-
ronmental measurements, and biologic
markers; this underscores the need for
development and refinement of methods
for handling multiple measures. Biologic
markers themselves, as measures of expo-
sure, effect, or susceptibility, are an area
where additional methodologic development
would be desirable.
A second important aspect of method-
ologic research relates to sensitivity analyses
and other approaches for estimating the
uncertainty in measurement of exposure
and dose. Included in this category would
be validation studies to compare a gold
standard with a more error-prone exposure
measurement in order to allow for correc-
tion ofbias in the analysis stage ofresearch.
Consideration needs to be given to the
costs and benefits of investigating measure-
ment error in the primary study or in a sub-
study (which could be carried out intemally
orextemally inrelation to theprimarystudy).
A final area that deserves attention is mea-
surement error in covariates, which can be as
important as measurement error in the
exposure oroutcomevariables. eg
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